Trial Profile
A phase III, seven-day randomised, double-blind, placebo-controlled, parallel group study to assess efficacy of Donepezil for reducing the incidence and severity of Post-Operative Delirium after an elective total hip or knee replacement in patients over 65 years old
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Acronyms D-POD3; DPOD-III
- 29 Jul 2019 Status changed from suspended to completed.
- 24 Feb 2009 New trial record